Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Glycorex Transplantation (GTAB B): Glycosorb[®] ABO used at the largest heart transplant center in Germany

Today, the Herz- und Diabeteszentrum Nordrhein-Westfalen in Bad Oeynhausen has announced in a press release  that their first blood group incompatible heart transplant using Glycosorb® ABO has been performed and with excellent results. The transplant was performed on a two-year-old girl, and she has now been able to celebrate her two-year-old birthday at home. The girl came to the hospital five months ago as a result of an incurable genetic heart muscle disease

Brighter publishes supplementary prospectus

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Brighter AB (publ) (“Brighter” or the “Company”) has established a supplement (the "Supplementary Prospectus") in addition to the EU growth prospectus regarding subscription of units in the ongoing rights issue (the “Rights Issue”) that

Kwiff Joins Forces with Xtremepush to Power Player Outreach Strategy

Kwiff , the super-charged betting service, has partnered with global Multi-Channel Experience and Engagement Marketing provider Xtremepush.This agreement allows kwiff to add even more momentum to its progressive player outreach strategy which forms an integral role in the company’s growth. kwiff’s engagement and retention strategy is executed through communicating with players in a highly personalised and timely manner.  Working with Xtremepush has shaped kwiff’s strategy by utilising personalised notifications for games or events that are relevant to them based on

BERGENBIO ANNOUCES FIRST PATIENT RANDOMIZED IN BEMCENTINIB TRIAL IN EU-SOLIDACT PLATFORM FOR HOSPITALIZED COVID-19 PATIENTS

BERGEN, Norway, September 27, 2022 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharma-ceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, and Oslo University Hospital announced today that the first patient has been included in a study of BerGenBio’s oral, highly selective AXL inhibitor, bemcentinib, as part of the EU-SolidAct trial in hospitalized COVID-19 patients.   The EU-SolidAct trial (European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial) is part of EU-RESPONSE, a pan-European research

Sivers Semiconductors receives purchase orders of 900 kUSD (10 MSEK*) from European satellite communications company

Sivers Semiconductors AB (“Sivers”) today announces that its business unit, Sivers Wireless, has received purchase orders for engineering activities (750 kUSD) and acceleration fees (150 kUSD) to speed up manufacturing of beamformer ICs at a total value of 900 kUSD (approximately 10 MSEK*).The engineering activities have started for this new project. The acceleration fee purchase order is a consequence of an ongoing development contract from MixComm, a company acquired by Sivers and now integrated in Sivers Wireless. The first generation beamformer ICs have been developed during the last

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release September 27, 2022 at 3:50 p.m. Nokian Tyres has received an announcement from BlackRock, Inc. on September 27, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the indirect holding in Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below the level of 5% of the share capital of Nokian Tyres plc, as a result of share transactions concluded on September 26, 2022. Total positions of BlackRock, Inc. and its funds subject to the notification: +----------------+----------

Lipum gets approval to start Phase 1 clinical trial with drug candidate SOL-116

Press release: Umeå, 27 September, 2022. Lipum AB (publ) announces today that the CTA (clinical trial application) for the drug candidate SOL-116 has been approved by the regulatory authorities in The Netherlands.The study that includes healthy volunteers and patients with rheumatoid arthritis will be carried out at QPS BV facility in Groningen, Netherlands. The study will be conducted as a dose escalation study by beginning with a very low dose and then gradually increasing the dose. The study is planned to start in October. “As planned, the clinical trial application has been approved

Ruter expands collaboration with Nobina by exercising option for additional electric buses

Ruter has chosen to expand its collaboration with Nobina in conjunction with the exercise of an option for 14 electric articulated buses to operate on route 23 between Lysaker and Simensbråten. The option is an addendum to the contract secured by Nobina in June 2022, when Nobina secured a renewed and extended contract to operate and develop city transport services in Oslo and the surrounding areas.The option for 14 scheduled electric articulated buses means route 23 will be fully electrified when services begin operating in December 2023, and is part of Nobina’s promise to always provide

Inspired by the river – the undulating Våghuset contributes to a new expanding district in Gothenburg

Våghuset was designed to represent the heart of Gothenburg, with an undulating façade it blends in perfectly between the water and the urban environment. Both the exterior and the interior represent life and movement, and in 2022 the wavy building will welcome it first tenants. A spectacular glass façade from WICONA covers the building and reflects the city's life with its full-covering glass that runs from floor to floor. The 10,000 square meter building has 13 floors, and every floor is designed to be customed accordingly to tenants needs and wishes. The tenants will have access

Troax appoints new Regional Director for North America

Hillerstorp 27th of September 2022, 14:30 CETAs Troax projects advance, new increased demands are placed on our organization. Troax has therefore decided to strengthen the organization in the USA and hired Jose Nuñez as a new Regional Director for the American operations. He will take up his position on October 4, 2022. This gives the opportunity to further develop the organization and customer relations in North America. "In order for us to stay one step ahead and maintain our world-leading position, we are happy to now have hired Jose Nuñez, who will contribute with significant

Announcement of the 2022 Nobel Prize in Physiology or Medicine

The Nobel Prize in Physiology or Medicine 2022 will be announced on Monday 3 October 2022 at 11.30 am (at the earliest).Press conference in the Wallenberg Hall, Nobel ForumNobels väg 1, Karolinska Institutet, Solna, Sweden.Printed matter will be made available at the press conference. The announcement will also be made on the Nobel Foundation website http://www.nobelprize.org/ and on the Nobel Assembly website www.nobelprizemedicine.org Press accreditation is obligatory, for registration please e-mail Nobelforum@nobelprizemedicine.org

Accedian and Cisco Provide Unparalleled Network Performance Monitoring and Analytics for Zain Kuwait

MONTREAL, Canada – September 27, 2022 – Accedian  and Cisco today announced that they are helping Zain Kuwait automate its network with increased network visibility and service assurance to deliver superior B2B customer experiences. Zain Kuwait, the leading digital service provider in the country, partnered with Accedian and Cisco to enhance visibility and insight into its network. With the integration of Accedian Skylight  into Cisco’s Crosswork Network Automation platform 

Company Announcement No. 106, 2022 - Fixing of coupons with effect as from 1 October 2022

The coupons for the Capped floaters listed below will be changed taking effect 1 October 2022. The new coupons will be in force from 1 October 2022 – 31 March 2023.   Capped floater with a 5 per cent interest rate cap, CF   DK0002015106, maturity 2038, new coupon as per 1 October 2022:   2.99% p.a.   Capped floater with a 5 per cent interest rate cap, CF OA DK0002015296, maturity 2038, new coupon as per 1 October 2022:   2.99% p.a.   Capped floater with a 6 per cent interest rate cap, CF DK0002021427, maturity 2041, new coupon as per 1 October 2022:   2.64% p.a.

GAMOMAT Strengthens Fire Respins Series with Alexandria Fire Launch

GAMOMAT , one of the leading independent slot game developers, is releasing the latest game from its fantastic Fire Respins series, Alexandria Fire, on 29th September.This is the fourth title from the Fire Respins series and Alexandria Fire evolves in the Mediterranean port city in Egypt. Alexandria’s seafront has forever been protected by the beacon of the Pharos of Alexandria which was lit by patroness Isis. Today, the light threatens to dwindle, and it’s up to a hero with magical powers and Isis to return the flame to former glory.  Alexandria Fire’s Reveal

Qt Group Plc’s financial reporting in 2023

Qt Group Plc, stock exchange release, September 27, 2022 at 2:00 pm EESTQt Group Plc will publish its Financial Statements Bulletin and Annual Report, two Interim Statements and Half-Year Report in 2023 as follows: · Financial Statements Bulletin and Annual Report 2022: Thursday, February 16, 2023 · Interim Statement January-March 2023: Friday, April 28, 2023 · Half-Year Report January-June 2023: Thursday, August 3, 2023 · Interim Statement January-September 2023: Thursday, October 26, 2023 Qt Group Plc's Annual General Meeting is planned to be held on Tuesday, March 14,

Aiforia Technologies Plc – Managers’ Transactions

Aiforia Technologies Plc COMPANY RELEASE, MANAGERS’ TRANSACTIONS 27 September 2022 02:00 p.m. EEST____________________________________________ Person subject to the notification requirementName: Jukka TapaninenPosition: Chief Executive Officer Issuer: Aiforia Technologies OyjLEI: 743700TJRVBX7420Y723Notification type: INITIAL NOTIFICATIONReference number: 19951/4/4 ____________________________________________ Transaction date: 2022-09-22Venue not applicableInstrument type: SHAREISIN: FI4000507934Nature of the transaction: SUBSCRIPTION(X) Linked to stock

Valmet to supply key technology for Cheng Loong’s new board machine in Vietnam

Valmet Oyj’s press release on September 27, 2022 at 2:00 p.m. EESTValmet will supply the Cheng Loong Binh Duong Paper Company with key process technology for its new containerboard machine 23 (BM 23) at the company’s Ben Cat mill in Binh Duong Province in Vietnam. Valmet’s delivery includes approach flow systems, headboxes, a press section, a sizer, process air systems, a winder, automation systems and Industrial Internet solutions. The order is included in Valmet’s orders received of the third quarter 2022. Its value will not be disclosed, but such an order is typically worth between

Meet new ISAB Board member Jan Hellqvist: “there is a major opportunity for ISAB as a service provider for SME respiratory drug developers”

With over 30 years in the life science and pharma industries and deep roots in respiratory, Inhalation Sciences' new Board member Jan Hellqvist has extensive experience growing SMEs to produce strong profit and growth. What are the key opportunities he sees for ISAB?“A big challenge for many small- to mid-size enterprises (SMEs) developing respiratory products is finding a service provider who can really help them develop the skills, organization and instruments they need to take a respiratory drug from discovery through to the preclinical stage” says new ISAB Board member Jan Hellqvist.

Bulletin from the extraordinary general meeting in Qlife Holding AB on 27 September 2022

Today, on 27 September 2022, an extraordinary general meeting was held in Qlife Holding AB. A summary of the adopted resolutions follows below. All resolutions were adopted with the required majority.Resolution on amendment of the Articles of Association The extraordinary general meeting resolved in accordance with the proposal from the board of directors to amend the provisions in the Articles of Association regarding the limits for the company’s share capital and the number of shares. Resolution on approval of the board of directors’ resolution on rights issue of units The

Prostatype Genomics continues to strengthen the commercial organization

Prostatype Genomics continues to strengthen the European sales organization and has hired Albin Bremer as sales manager responsible for the Nordic market."During the past year, we have taken steps to build up our commercial organization in selected markets in Europe. I am happy to have Albin on board as his broad and deep network of contacts in Nordic urology is important to us. Combined with Albin's commercial competence, we have already noted concrete progress, which I am happy to state. From an international perspective, the home market is also always important to refer to and therefore

Veidekke: Anticipates boost in the water, sewerage and energy markets

Veidekke's forecasts for the next two years point to a more muted construction market. In general, transport and construction activities are expected to remain at a high level, but private and commercial construction is expected to decline. The water, sewerage and energy market segments are expected to increase significantly going forward.Following a record 2022 and very high activity over several years, Veidekke is expecting the  construction and civil engineering market volume to drop by 3 % in 2023 and 1 % in 2024. The forecasts represent Veidekke’s best judgment based on current market

DexTech Medical announces upcoming multiple myeloma study

The application for an Fas1 study regarding the effect of OsteoDex on patients with multiple myeloma (MM) was approved and granted permission by the Medical Products Agency on August 10, 2022. The study will include 20 patients and be conducted at 4-5 hospitals in Sweden and other Nordic countries. Studyn is expected to start in Q1 2023 and be completed during Q4, 2024.  Principal investigator (PI) is Dr Katarina Uttervall, MD, PhD, Division of Hematology/HERM, Karolinska University Hospital, Huddinge. The main blood markers will be analyzed at the Central Laboratory, Karolinska University

Lagercrantz acquires Tebul Oy

Lagercrantz has today acquired 80% of the shares in Tebul Oy, a leading producer of watertight electric sliding doors.Tebul is a leading manufacturer of watertight electric sliding doors for ships. The doors are part of the watertight bulkheads in the hull of the ships. The customers are mainly European shipyards that build yachts, cruise ships and ferries. Tebul is based in Lieto in southwestern Finland. The company has a turnover of around 5 million Euros with good profitability. For more information about the company, please, visit https://tebul.fi/. "Tebul is the market leader in

The Nomination Committee for Humana AB's 2023 AGM has been constituted

The members of the Nomination Committee for Humana AB’s Annual General Meeting in 2023 have now been appointed.According to the instructions adopted at the General Meeting Humana AB shall have a Nomination Committee comprising one representative for each of the four principal shareholders in terms of votes and the Chairman of the Board. Based on the ownership structure as of August 31, 2022, the following individuals have been appointed to members of the Nomination Committee for the 2023 Annual General Meeting: · Fredrik Strömholm, representative from Impilo Care AB, Chairman of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top